{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T21:02:11Z","timestamp":1775509331628,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":235,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["BIO15\/CA\/022\/BC"],"award-info":[{"award-number":["BIO15\/CA\/022\/BC"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["IT989-16"],"award-info":[{"award-number":["IT989-16"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.critrevonc.2021.103247","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T11:47:23Z","timestamp":1611748043000},"page":"103247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-9321","authenticated-orcid":false,"given":"Javier","family":"Arzuaga-Mendez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lopez-Santillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Garcia-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elixabet","family":"Lopez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idoia","family":"Martin-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2021.103247_bib0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjh.12570","article-title":"Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database","volume":"163","author":"Ban-Hoefen","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12896-018-0421-6","article-title":"Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal","volume":"18","author":"Brown","year":"2018","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","article-title":"Transformed follicular non-Hodgkin lymphoma","volume":"125","author":"Casulo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41375-018-0230-x","article-title":"MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells","volume":"33","author":"Cerna","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","article-title":"The miR-17-92 family of microRNA clusters in development and disease","volume":"18","author":"Concepcion","year":"2012","journal-title":"Cancer J."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0030","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1182\/blood-2010-10-312231","article-title":"Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1","volume":"117","author":"Craig","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","article-title":"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia","volume":"124","author":"Cui","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2018.07.005","article-title":"New concepts in follicular lymphoma biology: from BCL2 to epigenetic regulators and non-coding RNAs","volume":"45","author":"Devan","year":"2018","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2353\/jmoldx.2008.070153","article-title":"Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded Tissues","volume":"10","author":"Doleshal","year":"2008","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0050","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/labinvest.2012.129","article-title":"The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies","volume":"92","author":"Fassina","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10428194.2019.1675877","article-title":"The role of MYC in the transformation and aggressiveness of \u2018indolent\u2019 B-cell malignancies","volume":"61","author":"Filip","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/10428194.2016.1228932","article-title":"The significance of FOXP1 in diffuse large B-cell lymphoma","volume":"58","author":"Gascoyne","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0070","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3324\/haematol.2016.143891","article-title":"ICGC MMML-Seq Project, Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis","volume":"101","author":"Hezaveh","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0075","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin\u2019s lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2016.09.011","article-title":"MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells","volume":"46","author":"Jablonska","year":"2017","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbagrm.2014.04.003","article-title":"MicroRNAs as regulators and mediators of c-MYC function","volume":"1849","author":"Jackstadt","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12185-014-1606-y","article-title":"The role of microRNAs in lymphopoiesis","volume":"100","author":"Johanson","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0100","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","article-title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","volume":"128","author":"Jurinovic","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0105","doi-asserted-by":"crossref","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0110","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-03-691345","article-title":"Can histologic transformation of follicular lymphoma be predicted and prevented?","author":"Kridel","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hoc.2020.02.010","article-title":"The biological basis of histologic transformation","volume":"34","author":"Kumar","year":"2020","journal-title":"Hematol. Oncol. Clin."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0120","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2017-11-764365","article-title":"Critical influences on the pathogenesis of follicular lymphoma","volume":"131","author":"K\u00fcppers","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/cancers11020144","article-title":"Systematic review of the potential of MicroRNAs in diffuse large B cell lymphoma","volume":"11","author":"Larrabeiti-Etxebarria","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0130","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.22800","article-title":"MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma","volume":"121","author":"Lawrie","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0135","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Lawrie","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0140","doi-asserted-by":"crossref","first-page":"577890","DOI":"10.3389\/fonc.2020.577890","article-title":"The role of noncoding RNAs in B-Cell lymphoma","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0145","doi-asserted-by":"crossref","first-page":"109687","DOI":"10.1016\/j.biopha.2019.109687","article-title":"MicroRNA-9 and breast cancer","volume":"122","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/leu.2010.230","article-title":"Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin\u2019s B-cell lymphomas","volume":"25","author":"Lin","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0155","doi-asserted-by":"crossref","first-page":"22850","DOI":"10.18632\/oncotarget.25230","article-title":"Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review","volume":"9","author":"Lopez-Santillan","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0160","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.18632\/oncotarget.24987","article-title":"MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma","volume":"9","author":"Malpeli","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0165","doi-asserted-by":"crossref","first-page":"29753","DOI":"10.18632\/oncotarget.25707","article-title":"MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways","volume":"9","author":"Malpeli","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2013-09-527234","article-title":"miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1","volume":"124","author":"Mraz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0175","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-cell lymphomas: how a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0180","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1182\/blood-2018-06-855502","article-title":"miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels","volume":"132","author":"Musilova","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0185","doi-asserted-by":"crossref","first-page":"e00822","DOI":"10.7554\/eLife.00822","article-title":"A component of the miR-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis","volume":"2","author":"Olive","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.intimp.2016.07.006","article-title":"MicroRNA expression profiling of Chinese follicular lymphoma by microarray: a preliminary study","volume":"39","author":"Pan","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0195","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2012-12-473090","article-title":"The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop","volume":"122","author":"Psathas","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0200","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.1501982","article-title":"NKG2D-NKG2D ligand interaction inhibits the outgrowth of naturally arising low-grade B cell lymphoma in vivo","volume":"196","author":"Raju","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0205","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0210","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"HAEMACARE Working Group, Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0215","doi-asserted-by":"crossref","first-page":"881","DOI":"10.5858\/arpa.2015-0482-SA","article-title":"The pathology of reactive lymphadenopathies: a discussion of common reactive patterns and their malignant mimics","volume":"140","author":"Slack","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2005.06.030","article-title":"Silence from within: endogenous siRNAs and miRNAs","volume":"122","author":"Sontheimer","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/2193-1801-3-288","article-title":"Determination of abnormally expressed microRNAs in bone marrow smears from patients with follicular lymphomas","volume":"3","author":"Takei","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.humpath.2015.11.011","article-title":"miR-31 and miR-17-5p levels change during transformation of follicular lymphoma","volume":"50","author":"Thompson","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0235","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/gad.1399806","article-title":"Control of translation and mRNA degradation by miRNAs and siRNAs","volume":"20","author":"Valencia-Sanchez","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0240","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2014-01-553412","article-title":"FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-\u03baB to promote survival of human B cells","volume":"124","author":"van Keimpema","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179645","article-title":"Comparison of the miRNA expression profiles in fresh frozen and formalin-fixed paraffin-embedded tonsillar tumors","volume":"12","author":"Vojtechova","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0250","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","article-title":"A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors","volume":"124","author":"Voorhoeve","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0255","first-page":"1315","article-title":"Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level","volume":"37","author":"Wang","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103247_bib0260","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3324\/haematol.2011.048132","article-title":"MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response","volume":"97","author":"Wang","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0265","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0270","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2008-09-178186","article-title":"Patterns of microRNA expression characterize stages of human B-cell differentiation","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0275","doi-asserted-by":"crossref","first-page":"e45133","DOI":"10.1371\/journal.pone.0045133","article-title":"TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2021.103247_bib0280","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-019-0977-3","article-title":"MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1\/PD-L1-mediated lymphoma cell interaction with CD8+T cells","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol. Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:37:42Z","timestamp":1760902662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842821000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":56,"alternative-id":["S1040842821000354"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103247","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103247"}}